Nasdaq Grants BIOLASE 180-Day Extension To Meet Minimum Bid Price Requirement And Enters Into Favorable Credit Agreement Amendment
Nasdaq Grants BIOLASE 180-Day Extension To Meet Minimum Bid Price Requirement And Enters Into Favorable Credit Agreement Amendment PR Newswire FOOTHILL RANCH, Calif. , Nov. 23, 2021 /PRNewswire/ — BIOLASE, Inc. (NASDAQ: BIOL), the global leader more...
SeaSpine Announces Full Commercial Launch of the Admiral(TM) ACP System
CARLSBAD, Calif., Nov. 23, 2021 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of its more...
Adamis Pharmaceuticals Regains Compliance with NASDAQ Continued Listing Requirements
SAN DIEGO, Nov. 23, 2021 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdose, respiratory and inflammatory disease, today announced that it has received more...
Fonar Board of Directors Appoints Independent Director
Melville, New York–(Newsfile Corp. – November 23, 2021) – FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning, today announced that on November 17, 2021, its board of directors appointed John Collins as a replacement more...
Motus GI to Present at Two Upcoming Investor Conferences in December 2021
FORT LAUDERDALE, Fla., Nov. 23, 2021 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency more...
Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Adamas Pharmaceuticals Tender Offer
ROCKVILLE, Md., Nov. 23, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) today announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) with respect to Supernus’ proposed more...
3 Top-Ranked Stocks to Buy for Solid Earnings Acceleration
Studies have shown that a majority of successful stocks had seen an acceleration in earnings before an uptick in the stock price. In case of earnings growth, you pay for something already reflected in the more...
BIOLASE To Present At The Benchmark Company Discovery One-On-One Virtual Investor Conference On December 2, 2021
BIOLASE To Present At The Benchmark Company Discovery One-On-One Virtual Investor Conference On December 2, 2021 PR Newswire FOOTHILL RANCH, Calif. , Nov. 23, 2021 /PRNewswire/ — BIOLASE, Inc. (NASDAQ: BIOL), the global leader in more...
Adamis Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Corporate Update
Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ET SAN DIEGO, Nov. 22, 2021 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products more...
Chembio Diagnostic Systems Prevails in International Arbitration Against BioSure (UK) Ltd
HAUPPAUGE, N.Y., Nov. 22, 2021 (GLOBE NEWSWIRE) — Chembio Diagnostic Systems Inc. (“Chembio”), a subsidiary of Chembio Diagnostics, Inc. (Nasdaq: CEMI), received an international arbitration award Thursday, November 18, 2021 against BioSure (UK) Ltd, Chembio’s more...